Contact Us

The Leading Full-Service Ophthalmology CRO

Lexitas delivers tailored approaches, rigorous quality standards, and unwavering commitment to operational success.

Contact Us Learn about our Services

Why work with us

Lexitas is a specialized clinical research organization with over 15 years dedicated exclusively to ophthalmology.

1

Deep ophthalmology expertise

Our team of ophthalmologists, optometrists, clinical operations specialists, and imaging experts have more than 475 years of combined experience in ophthalmology and clinical research.

2

Personalized services

Our operating procedures and systems allow us to tailor our work to meet the specific needs of each protocol, customer, and project.

3

End-to-end expert guidance

Our extensive capabilities and experience across all ophthalmic subspecialties enable us to guide you through every stage of the development process.

1

Deep ophthalmology expertise

Our team of ophthalmologists, optometrists, clinical operations specialists, and imaging experts have more than 475 years of combined experience in ophthalmology and clinical research.

2

Personalized services

Our operating procedures and systems allow us to tailor our work to meet the specific needs of each protocol, customer, and project.

3

End-to-end expert guidance

Our extensive capabilities and experience across all ophthalmic subspecialties enable us to guide you through every stage of the development process.

Learn How We Can Help

Lexitas is your partner for ophthalmic clinical research at every stage.

What our clients say

Liza Ko

Chief Financial Officer, MingMed Biotechnology

Lexitas truly operated as an extension of the MingMed team, delivering hands-on support across monitoring, data management, and vendor coordination. Their meticulous approach to SDV and database lock planning, combined with strong site collaboration and seamless vendor alignment, enabled us to achieve aggressive timelines without compromising data quality.
Mike Burr

Vice President Product Development, iVeena

Partnering with Lexitas has been an excellent experience. Their deep ophthalmology expertise brought real value throughout the study and reinforced the importance of working with a specialized CRO that understands the nuances of this space. The team was highly collaborative, responsive, and easy to work with, consistently providing clear communication and practical guidance. Most importantly, they delivered by completing all major study milestones ahead of schedule. We would confidently recommend them to any organization seeking a knowledgeable and reliable ophthalmology-focused CRO.
Morgan Stokes

Executive Director Clinical Operations, Baxis Pharmaceuticals

The Lexitas team was a true partner throughout this project. Faced with evolving site feasibility requirements, they consistently thought creatively, explored non-traditional site options, and went above and beyond to identify solutions that met our needs. The team proactively addressed hurdles that arose with effective solutions. Their flexibility, responsiveness, and collaborative approach were greatly appreciated and truly set them apart. It has been a pleasure working with the Lexitas team.
Gulab Zode

Chief Executive Officer, Occuflow

We were extremely impressed with the Lexitas Medical and Regulatory Writing team and consultancy network. Their deep understanding of ophthalmic product development and regulatory strategy brought tremendous value to our Product Development Plan. Beyond their technical expertise, they were professional, responsive, and easy to work with at every stage of the project. The team’s ability to synthesize complex information into a clear, actionable plan helped position our program for success. We highly recommend Lexitas to any company seeking experienced ophthalmology development support.
Justin Hanes

Chief Executive Officer, Novus Vision

It has been a pleasure working with Lexitas. Their expertise in ophthalmology, attention to detail, and commitment to timelines made a complex process manageable and collaborative. Their proactive communication and problem-solving approach gave us confidence at every stage, and ultimately helped ensure the study ran smoothly from start to finish.
Rob Beathard

Chief Strategy Officer, jCyte

“Working with this team has been a great experience thanks to their ‘white glove’ service and collaborative approach. We truly value their operational insights, which have helped us avoid potential issues as we work towards initiating our next trial. Their expertise and attention to detail has ensured a smoother process from the very start of our engagement.”
Sonja Krosser

VP Preclinical & Clinical Development, Novaliq

“We value Lexitas as a full-service CRO that shares our passion for ophthalmology and our mission to bring innovative eye care treatments to patients. In our current project, Lexitas exceeded expectations by delivering the last patient-in well ahead of schedule.”
David Esposito

Chief Executive Officer, ONL Therapeutics

“Lexitas was an instrumental partner in our study, delivering CRO services as well as access to their integrated Reading Center. With an exclusive focus on ophthalmology, their team was equipped to provide expert guidance and support throughout the project.”
Ben Yerxa

Chief Executive Officer, Opus Genetics

“As a small company, we prefer working with smaller CROs where personal connections matter. It’s about interacting directly with team members and having direct access to the CEO.”
Houman Hemmati, MD, PHD

Co-founder, Levation Pharma

“Lexitas isn’t a CRO – it’s truly a partner committed to the success of each clinical program.”
Clare Guererro

Senior Director, Clinical Operations, PYC Therapeutics

“We’ve had a wonderful experience working with Lexitas. Their dedication to excellence and seamless collaboration has made them an invaluable partner. Their expertise and commitment to our Quokka trial have consistently delivered outstanding results. We couldn’t ask for a better vendor to support our observational trial and research efforts.”
Madhu Cherukury

Chief Executive Officer, Allgenesis

“The Lexitas team has been a pleasure to work with, providing exceptional support throughout our clinical program, and providing an enjoyable collaborative effort in writing the CSR.”
Sean McDonald

Chief Executive Officer, Ocugenix

“We chose Lexitas because of their exceptional experience in the ophthalmology field, with established relationships with key opinion leaders and clinical sites. Their expert management of our study will enable us to move ahead with our clinical development plan.”
Liza Ko

Chief Financial Officer, MingMed Biotechnology

Lexitas truly operated as an extension of the MingMed team, delivering hands-on support across monitoring, data management, and vendor coordination. Their meticulous approach to SDV and database lock planning, combined with strong site collaboration and seamless vendor alignment, enabled us to achieve aggressive timelines without compromising data quality.
Mike Burr

Vice President Product Development, iVeena

Partnering with Lexitas has been an excellent experience. Their deep ophthalmology expertise brought real value throughout the study and reinforced the importance of working with a specialized CRO that understands the nuances of this space. The team was highly collaborative, responsive, and easy to work with, consistently providing clear communication and practical guidance. Most importantly, they delivered by completing all major study milestones ahead of schedule. We would confidently recommend them to any organization seeking a knowledgeable and reliable ophthalmology-focused CRO.
Morgan Stokes

Executive Director Clinical Operations, Baxis Pharmaceuticals

The Lexitas team was a true partner throughout this project. Faced with evolving site feasibility requirements, they consistently thought creatively, explored non-traditional site options, and went above and beyond to identify solutions that met our needs. The team proactively addressed hurdles that arose with effective solutions. Their flexibility, responsiveness, and collaborative approach were greatly appreciated and truly set them apart. It has been a pleasure working with the Lexitas team.
Gulab Zode

Chief Executive Officer, Occuflow

We were extremely impressed with the Lexitas Medical and Regulatory Writing team and consultancy network. Their deep understanding of ophthalmic product development and regulatory strategy brought tremendous value to our Product Development Plan. Beyond their technical expertise, they were professional, responsive, and easy to work with at every stage of the project. The team’s ability to synthesize complex information into a clear, actionable plan helped position our program for success. We highly recommend Lexitas to any company seeking experienced ophthalmology development support.
Justin Hanes

Chief Executive Officer, Novus Vision

It has been a pleasure working with Lexitas. Their expertise in ophthalmology, attention to detail, and commitment to timelines made a complex process manageable and collaborative. Their proactive communication and problem-solving approach gave us confidence at every stage, and ultimately helped ensure the study ran smoothly from start to finish.
Rob Beathard

Chief Strategy Officer, jCyte

“Working with this team has been a great experience thanks to their ‘white glove’ service and collaborative approach. We truly value their operational insights, which have helped us avoid potential issues as we work towards initiating our next trial. Their expertise and attention to detail has ensured a smoother process from the very start of our engagement.”
Sonja Krosser

VP Preclinical & Clinical Development, Novaliq

“We value Lexitas as a full-service CRO that shares our passion for ophthalmology and our mission to bring innovative eye care treatments to patients. In our current project, Lexitas exceeded expectations by delivering the last patient-in well ahead of schedule.”
David Esposito

Chief Executive Officer, ONL Therapeutics

“Lexitas was an instrumental partner in our study, delivering CRO services as well as access to their integrated Reading Center. With an exclusive focus on ophthalmology, their team was equipped to provide expert guidance and support throughout the project.”
Ben Yerxa

Chief Executive Officer, Opus Genetics

“As a small company, we prefer working with smaller CROs where personal connections matter. It’s about interacting directly with team members and having direct access to the CEO.”
Houman Hemmati, MD, PHD

Co-founder, Levation Pharma

“Lexitas isn’t a CRO – it’s truly a partner committed to the success of each clinical program.”
Clare Guererro

Senior Director, Clinical Operations, PYC Therapeutics

“We’ve had a wonderful experience working with Lexitas. Their dedication to excellence and seamless collaboration has made them an invaluable partner. Their expertise and commitment to our Quokka trial have consistently delivered outstanding results. We couldn’t ask for a better vendor to support our observational trial and research efforts.”
Madhu Cherukury

Chief Executive Officer, Allgenesis

“The Lexitas team has been a pleasure to work with, providing exceptional support throughout our clinical program, and providing an enjoyable collaborative effort in writing the CSR.”
Sean McDonald

Chief Executive Officer, Ocugenix

“We chose Lexitas because of their exceptional experience in the ophthalmology field, with established relationships with key opinion leaders and clinical sites. Their expert management of our study will enable us to move ahead with our clinical development plan.”
Liza Ko

Chief Financial Officer, MingMed Biotechnology

Lexitas truly operated as an extension of the MingMed team, delivering hands-on support across monitoring, data management, and vendor coordination. Their meticulous approach to SDV and database lock planning, combined with strong site collaboration and seamless vendor alignment, enabled us to achieve aggressive timelines without compromising data quality.
Mike Burr

Vice President Product Development, iVeena

Partnering with Lexitas has been an excellent experience. Their deep ophthalmology expertise brought real value throughout the study and reinforced the importance of working with a specialized CRO that understands the nuances of this space. The team was highly collaborative, responsive, and easy to work with, consistently providing clear communication and practical guidance. Most importantly, they delivered by completing all major study milestones ahead of schedule. We would confidently recommend them to any organization seeking a knowledgeable and reliable ophthalmology-focused CRO.
Morgan Stokes

Executive Director Clinical Operations, Baxis Pharmaceuticals

The Lexitas team was a true partner throughout this project. Faced with evolving site feasibility requirements, they consistently thought creatively, explored non-traditional site options, and went above and beyond to identify solutions that met our needs. The team proactively addressed hurdles that arose with effective solutions. Their flexibility, responsiveness, and collaborative approach were greatly appreciated and truly set them apart. It has been a pleasure working with the Lexitas team.
Gulab Zode

Chief Executive Officer, Occuflow

We were extremely impressed with the Lexitas Medical and Regulatory Writing team and consultancy network. Their deep understanding of ophthalmic product development and regulatory strategy brought tremendous value to our Product Development Plan. Beyond their technical expertise, they were professional, responsive, and easy to work with at every stage of the project. The team’s ability to synthesize complex information into a clear, actionable plan helped position our program for success. We highly recommend Lexitas to any company seeking experienced ophthalmology development support.
Justin Hanes

Chief Executive Officer, Novus Vision

It has been a pleasure working with Lexitas. Their expertise in ophthalmology, attention to detail, and commitment to timelines made a complex process manageable and collaborative. Their proactive communication and problem-solving approach gave us confidence at every stage, and ultimately helped ensure the study ran smoothly from start to finish.
Rob Beathard

Chief Strategy Officer, jCyte

“Working with this team has been a great experience thanks to their ‘white glove’ service and collaborative approach. We truly value their operational insights, which have helped us avoid potential issues as we work towards initiating our next trial. Their expertise and attention to detail has ensured a smoother process from the very start of our engagement.”
Sonja Krosser

VP Preclinical & Clinical Development, Novaliq

“We value Lexitas as a full-service CRO that shares our passion for ophthalmology and our mission to bring innovative eye care treatments to patients. In our current project, Lexitas exceeded expectations by delivering the last patient-in well ahead of schedule.”
David Esposito

Chief Executive Officer, ONL Therapeutics

“Lexitas was an instrumental partner in our study, delivering CRO services as well as access to their integrated Reading Center. With an exclusive focus on ophthalmology, their team was equipped to provide expert guidance and support throughout the project.”
Ben Yerxa

Chief Executive Officer, Opus Genetics

“As a small company, we prefer working with smaller CROs where personal connections matter. It’s about interacting directly with team members and having direct access to the CEO.”
Houman Hemmati, MD, PHD

Co-founder, Levation Pharma

“Lexitas isn’t a CRO – it’s truly a partner committed to the success of each clinical program.”
Clare Guererro

Senior Director, Clinical Operations, PYC Therapeutics

“We’ve had a wonderful experience working with Lexitas. Their dedication to excellence and seamless collaboration has made them an invaluable partner. Their expertise and commitment to our Quokka trial have consistently delivered outstanding results. We couldn’t ask for a better vendor to support our observational trial and research efforts.”
Madhu Cherukury

Chief Executive Officer, Allgenesis

“The Lexitas team has been a pleasure to work with, providing exceptional support throughout our clinical program, and providing an enjoyable collaborative effort in writing the CSR.”
Sean McDonald

Chief Executive Officer, Ocugenix

“We chose Lexitas because of their exceptional experience in the ophthalmology field, with established relationships with key opinion leaders and clinical sites. Their expert management of our study will enable us to move ahead with our clinical development plan.”

Partner with Lexitas for unparalleled expertise in ophthalmic clinical trials, ensuring timely and successful outcomes tailored to your study’s unique needs.

Contact Us